Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Concert Pharmaceuticals Broadens Management Team and Expands Product Advisory Board

Concert Pharmaceuticals 12.09.2009

Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV

Concert Pharmaceuticals 11.09.2009

Concert Pharmaceuticals Presents Clinical Results Demonstrating Reduced Drug-Drug Interactions with a Deuterium-Modified Compound

Concert Pharmaceuticals 09.14.2009

Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs

Concert Pharmaceuticals 06.02.2009

Concert Pharmaceuticals Granted Patents on Deuterium-Modified Compounds

Concert Pharmaceuticals 05.11.2009

Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347

Concert Pharmaceuticals 03.16.2009

Loading